• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去铁胺通过抑制ROS/HIF-1、Wnt/β-连环蛋白和p38MAPK/ERK信号通路来抑制急性淋巴细胞白血病进展。

Deferoxamine Inhibits Acute Lymphoblastic Leukemia Progression through Repression of ROS/HIF-1, Wnt/-Catenin, and p38MAPK/ERK Pathways.

作者信息

You Hongliang, Wang Dao, Wei Linlin, Chen Jiao, Li Huanhuan, Liu Yufeng

机构信息

Department of Hematology and Oncology, Children's Hospital, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

J Oncol. 2022 Feb 21;2022:8281267. doi: 10.1155/2022/8281267. eCollection 2022.

DOI:10.1155/2022/8281267
PMID:35237325
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8885176/
Abstract

Acute lymphoblastic leukemia (ALL) is the most common type of childhood cancer, with a feature of easy to induce multidrug resistance and relapse. Abundant studies have proved that iron overload strengthens the growth and metastasis of tumor cells. Herein, we found that deferoxamine (DFO) effectively decreased the concentration of intracellular iron in ALL cells. DFO inhibited proliferation, induced apoptosis, and obstructed cell cycle of ALL cells, whereas DFO and dextriferron (Dex) used in combination significantly decreased the sensitivity of ALL cells to DFO. Reactive oxygen species (ROS) level was reduced in ALL cells treated with DFO, and the combination of DFO and Dex reversed the effects of DFO. , DFO inhibited mouse tumor growth. Besides, cyclinD1, -catenin, c-Myc, hypoxia inducible factor 1 (HIF-1), p-p38MAPK, and p-ERK1/2 protein levels were significantly downregulated, and the levels of prolyl hydroxylase-2 (PHD-2) were upregulated after treated with DFO, whereas Dex treatment reversed those and . In conclusion, DFO inhibited the proliferation and ALL xenograft tumor growth, obstructed the cell cycle, and induced apoptosis of ALL cells, probably via inactivating the ROS/HIF-1, Wnt/-catenin, and p38MAPK/ERK signaling.

摘要

急性淋巴细胞白血病(ALL)是儿童期最常见的癌症类型,具有易于诱导多药耐药和复发的特点。大量研究证明,铁过载会增强肿瘤细胞的生长和转移。在此,我们发现去铁胺(DFO)能有效降低ALL细胞内铁的浓度。DFO抑制ALL细胞的增殖,诱导其凋亡,并阻碍细胞周期,而DFO与右丙亚胺(Dex)联合使用则显著降低ALL细胞对DFO的敏感性。用DFO处理的ALL细胞中活性氧(ROS)水平降低,DFO与Dex联合使用可逆转DFO的作用。此外,DFO抑制小鼠肿瘤生长。此外,经DFO处理后,细胞周期蛋白D1、β-连环蛋白、c-Myc、缺氧诱导因子1(HIF-1)、磷酸化p38丝裂原活化蛋白激酶(p-p38MAPK)和磷酸化细胞外信号调节激酶1/2(p-ERK1/2)的蛋白水平显著下调,脯氨酰羟化酶-2(PHD-2)水平上调,而Dex处理则逆转了这些变化。总之,DFO可能通过使ROS/HIF-1、Wnt/β-连环蛋白和p38MAPK/ERK信号失活,从而抑制ALL细胞的增殖和异种移植肿瘤生长,阻碍细胞周期,并诱导ALL细胞凋亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8885176/a3a8c9fd8b19/JO2022-8281267.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8885176/9114d06e22e5/JO2022-8281267.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8885176/7fcef134e11f/JO2022-8281267.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8885176/0310dbb57cc9/JO2022-8281267.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8885176/d0b55502a39f/JO2022-8281267.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8885176/f7293bf14097/JO2022-8281267.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8885176/a3a8c9fd8b19/JO2022-8281267.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8885176/9114d06e22e5/JO2022-8281267.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8885176/7fcef134e11f/JO2022-8281267.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8885176/0310dbb57cc9/JO2022-8281267.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8885176/d0b55502a39f/JO2022-8281267.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8885176/f7293bf14097/JO2022-8281267.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8885176/a3a8c9fd8b19/JO2022-8281267.006.jpg

相似文献

1
Deferoxamine Inhibits Acute Lymphoblastic Leukemia Progression through Repression of ROS/HIF-1, Wnt/-Catenin, and p38MAPK/ERK Pathways.去铁胺通过抑制ROS/HIF-1、Wnt/β-连环蛋白和p38MAPK/ERK信号通路来抑制急性淋巴细胞白血病进展。
J Oncol. 2022 Feb 21;2022:8281267. doi: 10.1155/2022/8281267. eCollection 2022.
2
Deferoxamine promotes MDA-MB-231 cell migration and invasion through increased ROS-dependent HIF-1α accumulation.去铁胺通过增加活性氧依赖性缺氧诱导因子-1α的积累促进MDA-MB-231细胞迁移和侵袭。
Cell Physiol Biochem. 2014;33(4):1036-46. doi: 10.1159/000358674. Epub 2014 Apr 4.
3
Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.去铁胺介导的低氧诱导因子-1α上调通过激活MPTP处理小鼠中的丝裂原活化蛋白激酶家族蛋白来预防多巴胺能神经元死亡。
Exp Neurol. 2016 Jun;280:13-23. doi: 10.1016/j.expneurol.2016.03.016. Epub 2016 Mar 18.
4
Cobalt induces hypoxia-inducible factor-1alpha (HIF-1alpha) in HeLa cells by an iron-independent, but ROS-, PI-3K- and MAPK-dependent mechanism.钴通过一种不依赖铁,但依赖活性氧(ROS)、磷脂酰肌醇-3激酶(PI-3K)和丝裂原活化蛋白激酶(MAPK)的机制,在HeLa细胞中诱导缺氧诱导因子-1α(HIF-1α)。
Free Radic Res. 2006 Aug;40(8):847-56. doi: 10.1080/10715760600730810.
5
Deferoxamine preconditioning activated hypoxia-inducible factor-1α and MyD88-dependent Toll-like receptor 4 signaling in intestinal stem cells.去铁胺预处理激活了肠道干细胞中的缺氧诱导因子-1α和髓样分化因子88依赖的Toll样受体4信号通路。
J Pediatr Surg. 2018 Nov;53(11):2349-2356. doi: 10.1016/j.jpedsurg.2018.01.023. Epub 2018 Feb 6.
6
Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats.去铁胺预处理增强间充质干细胞在体外和链脲佐菌素诱导糖尿病大鼠体内的归巢。
Expert Opin Biol Ther. 2013 Jul;13(7):959-72. doi: 10.1517/14712598.2013.782390. Epub 2013 Mar 28.
7
Vasculogenesis and angiogenesis initiation under normoxic conditions through Wnt/β-catenin pathway in gliomas.在胶质瘤的常氧条件下,通过 Wnt/β-catenin 通路进行血管生成和血管发生启动。
Rev Neurosci. 2018 Jan 26;29(1):71-91. doi: 10.1515/revneuro-2017-0032.
8
Deferoxamine suppresses esophageal squamous cell carcinoma cell growth via ERK1/2 mediated mitochondrial dysfunction.去铁胺通过 ERK1/2 介导的线粒体功能障碍抑制食管鳞癌细胞生长。
Cancer Lett. 2018 Sep 28;432:132-143. doi: 10.1016/j.canlet.2018.06.012. Epub 2018 Jun 12.
9
Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1α.去铁胺通过积累缺氧诱导因子-1α增强糖尿病大鼠的新生血管形成并加速伤口愈合。
Diabetes Res Clin Pract. 2013 Jul;101(1):62-71. doi: 10.1016/j.diabres.2013.04.012. Epub 2013 May 28.
10
Acute course of deferoxamine promoted neuronal differentiation of neural progenitor cells through suppression of Wnt/β-catenin pathway: a novel efficient protocol for neuronal differentiation.去铁胺的急性处理通过抑制Wnt/β-连环蛋白信号通路促进神经祖细胞的神经元分化:一种新型高效的神经元分化方案
Neurosci Lett. 2015 Mar 17;590:138-44. doi: 10.1016/j.neulet.2015.01.083. Epub 2015 Feb 4.

引用本文的文献

1
Targeting hypoxia-inducible factor 1α in chronic graft-versus-host disease to enhance graft-versus-leukemia responses: implications for nanotherapeutics.靶向慢性移植物抗宿主病中的缺氧诱导因子1α以增强移植物抗白血病反应:对纳米疗法的启示
Front Immunol. 2025 Jul 28;16:1605669. doi: 10.3389/fimmu.2025.1605669. eCollection 2025.
2
Oxidative Stress: Signaling Pathways, Biological Functions, and Disease.氧化应激:信号通路、生物学功能与疾病
MedComm (2020). 2025 Jul 1;6(7):e70268. doi: 10.1002/mco2.70268. eCollection 2025 Jul.
3
Distinguishing acute leukemia subtypes: The role of hsa_circ_0012152 and hsa_circ_0020093 in peripheral blood.

本文引用的文献

1
Iron overload regulate the cytokine of mesenchymal stromal cells through ROS/HIF-1α pathway in Myelodysplastic syndromes.铁过载通过活性氧/缺氧诱导因子-1α途径调节骨髓增生异常综合征中间充质基质细胞的细胞因子。
Leuk Res. 2020 Apr 25;93:106354. doi: 10.1016/j.leukres.2020.106354.
2
Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity.铁可保护儿童急性淋巴细胞白血病细胞免受甲氨蝶呤的细胞毒性。
Cancer Med. 2020 May;9(10):3537-3550. doi: 10.1002/cam4.2982. Epub 2020 Mar 16.
3
How to manage iron toxicity in post-allogeneic hematopoietic stem cell transplantation?
区分急性白血病亚型:hsa_circ_0012152和hsa_circ_0020093在外周血中的作用。
Oncol Lett. 2025 May 7;30(1):330. doi: 10.3892/ol.2025.15076. eCollection 2025 Jul.
4
Modulation of Tumor Metabolism in Acute Leukemia by Plant-Derived Polymolecular Drugs and Their Effects on Mitochondrial Function.植物源多分子药物对急性白血病肿瘤代谢的调节及其对线粒体功能的影响
Molecules. 2025 Apr 16;30(8):1783. doi: 10.3390/molecules30081783.
5
Hypoxia Pathways in Parkinson's Disease: From Pathogenesis to Therapeutic Targets.帕金森病中的缺氧途径:从发病机制到治疗靶点。
Int J Mol Sci. 2024 Sep 29;25(19):10484. doi: 10.3390/ijms251910484.
6
Salvia Miltiorrhiza Injection Inhibited the Proliferation of AML Cells by Inducing Apoptosis through the p38MAPK Pathway.丹参注射液通过p38丝裂原活化蛋白激酶(p38MAPK)途径诱导细胞凋亡,从而抑制急性髓系白血病(AML)细胞的增殖。
Cell Biochem Biophys. 2025 Mar;83(1):1263-1275. doi: 10.1007/s12013-024-01560-x. Epub 2024 Sep 29.
7
Recent advances in potential therapeutic targets of ferroptosis‑associated pathways for the treatment of stroke (Review).铁死亡相关通路在脑卒中治疗中潜在治疗靶点的研究进展(综述)。
Mol Med Rep. 2024 Jul;30(1). doi: 10.3892/mmr.2024.13252. Epub 2024 May 24.
8
Iron chelators: as therapeutic agents in diseases.铁螯合剂:作为疾病治疗药物
Ann Med Surg (Lond). 2024 Mar 19;86(5):2759-2776. doi: 10.1097/MS9.0000000000001717. eCollection 2024 May.
9
Regulation of Hypoxia Dependent Reprogramming of Cancer Metabolism: Role of HIF-1 and Its Potential Therapeutic Implications in Leukemia.缺氧诱导的肿瘤代谢重编程调控:HIF-1 的作用及其在白血病治疗中的潜在意义。
Asian Pac J Cancer Prev. 2024 Apr 1;25(4):1121-1134. doi: 10.31557/APJCP.2024.25.4.1121.
10
Upregulation of miR-194-5p or silencing of PRC1 enhances radiotherapy sensitivity in esophageal squamous carcinoma cells.miR-194-5p的上调或PRC1的沉默增强了食管鳞状癌细胞的放射敏感性。
Heliyon. 2023 Nov 13;9(12):e22282. doi: 10.1016/j.heliyon.2023.e22282. eCollection 2023 Dec.
如何处理异基因造血干细胞移植后的铁中毒?
Expert Rev Hematol. 2020 Apr;13(4):299-302. doi: 10.1080/17474086.2020.1719359. Epub 2020 Feb 8.
4
Inflammation and Hypoxia: HIF and PHD Isoform Selectivity.炎症与缺氧:HIF 和 PHD 同工型选择性。
Trends Mol Med. 2019 Jan;25(1):33-46. doi: 10.1016/j.molmed.2018.10.006. Epub 2018 Nov 12.
5
Effects of Deferoxamine on Leukemia In Vitro and Its Related Mechanism.去铁胺对白血病的体外作用及其相关机制。
Med Sci Monit. 2018 Sep 24;24:6735-6741. doi: 10.12659/MSM.910325.
6
assessment of the role of DpC in the treatment of head and neck squamous cell carcinoma.评估DpC在头颈部鳞状细胞癌治疗中的作用。
Oncol Lett. 2018 May;15(5):7999-8004. doi: 10.3892/ol.2018.8279. Epub 2018 Mar 15.
7
Ironing out the role of the cyclin-dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity.消除细胞周期蛋白依赖性激酶抑制剂 p21 在癌症中的作用:新型铁螯合剂靶向 p21 表达和活性。
Free Radic Biol Med. 2019 Mar;133:276-294. doi: 10.1016/j.freeradbiomed.2018.03.027. Epub 2018 Mar 20.
8
High-Dose Deferoxamine Treatment Disrupts Intracellular Iron Homeostasis, Reduces Growth, and Induces Apoptosis in Metastatic and Nonmetastatic Breast Cancer Cell Lines.高剂量去铁胺治疗破坏细胞内铁稳态,降低转移性和非转移性乳腺癌细胞系的生长并诱导其凋亡。
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818764470. doi: 10.1177/1533033818764470.
9
Inhibitory Activity of Iron Chelators ATA and DFO on MCF-7 Breast Cancer Cells and Phosphatases PTP1B and SHP2.铁螯合剂ATA和DFO对MCF-7乳腺癌细胞及磷酸酶PTP1B和SHP2的抑制活性
Anticancer Res. 2017 Sep;37(9):4799-4806. doi: 10.21873/anticanres.11886.
10
Deferasirox has strong anti-leukemia activity but may antagonize theanti-leukemia effect of doxorubicin.地拉罗司具有较强的抗白血病活性,但可能会拮抗阿霉素的抗白血病作用。
Leuk Lymphoma. 2017 Sep;58(9):1-12. doi: 10.1080/10428194.2017.1280604. Epub 2017 Jan 31.